Risk of CVD in patients with autoimmune diseases

5' education - Oct. 12, 2022 - Prof. Naveed Sattar, MD, PhD - Glasgow, UK

Educational information

In the Cardiovascular Scene Investigation (CSI) series, investigators from Utrecht, the Netherlands report at the ESC congress, from the perspective of young investigators. They interview researchers/presenters about study results.

Faculty

Naveed Sattar, MD, PhD is Professor of Metabolic Medicine, University of Glasgow.

The interviewer is Marga Helmink, PhD candidate at the department of Vascular Medicine in UMC Utrecht, The Netherlands.

Disclosures

This recording was independently developed under auspices of EPCCS. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of EPCCS.

Find the discussed article online at The Lancet

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.